(Q88950417)

English

Characterization of dermatitis after PD-1/PD-L1 inhibitor therapy and association with multiple oncologic outcomes: A retrospective case-control study

scientific article published on 29 May 2018

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29857011%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Characterization of dermatitis after PD-1/PD-L1 inhibitor therapy and association with multiple oncologic outcomes: A retrospective case-control study (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29857011%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29857011%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

author name string

Charles Kyung Min Lee

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29857011%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Shufeng Li

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29857011%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Duy Cong Tran

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29857011%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Jinah Kim

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29857011%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Bernice Y Kwong

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29857011%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Anne Lynn S Chang

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29857011%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

publication date

29 May 2018

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29857011%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Journal of the American Academy of Dermatology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29857011%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

79

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29857011%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29857011%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

1047-1052

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29857011%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance

1 reference

https://pubmed.ncbi.nlm.nih.gov/29857011

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29857011

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overexpression of B7-H1 (PD-L1) significantly associates with tumor grade and postoperative prognosis in human urothelial cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/29857011

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCG-induced granulomata: associations with localized stage progression.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29857011

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/29857011

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/29857011

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/29857011

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/29857011

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29857011

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab

1 reference

https://pubmed.ncbi.nlm.nih.gov/29857011

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical analysis of lichenoid reactions in patients treated with anti-PD-L1 and anti-PD-1 therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/29857011

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/29857011

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Histopathological aspects of cutaneous erythematous-papular eruptions induced by immune checkpoint inhibitors for the treatment of metastatic melanoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29857011

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Eruptive Keratoacanthomas Associated With Pembrolizumab Therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29857011

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cutaneous Eruptions in Patients Receiving Immune Checkpoint Blockade: Clinicopathologic Analysis of the Nonlichenoid Histologic Pattern.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29857011

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atezolizumab in advanced non-small cell lung cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29857011

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.JAAD.2018.05.035

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29857011%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29857011%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29857011%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q88950417&oldid=1985835218"